NPR's science podcast Short Wave talks about why wolves are thriving in California, a new estimation of the world's insect species and the universe's earliest quasars.
England face an anxious wait ahead of their World Cup quarter-final showdown against Norway after a sickness bug hit their ...
Norway have issued a firm update regarding the health of their squad ahead of the crucial World Cup quarter-final against ...
The government is teaming up with Colossal Biosciences, a private company that claims to have revived extinct dire wolves, to store samples from at-risk animals and plants. By Carl Zimmer and Catrin ...
Colossal founder Ben Lamm and the broader Colossal team have announced a major breakthrough for the development of artificial eggs designed to help restore extinct bird species through a completely re ...
In an early step towards artificial wombs, a biotech company claims it’s developed a “fully artificial” chicken egg. The baby chicks were shifting and starting to pip—or trying to hatch. But not from ...
EDITOR’S NOTE: Call to Earth is a CNN editorial series committed to reporting on the environmental challenges facing our planet, together with the solutions. Rolex’s Perpetual Planet Initiative has ...
What does the Colossal Flower do? In Slay the Spire 2, you'll come across several events that ask you to make a choice that can have a big impact on the rest of your run. Usually these events have two ...
An animatronic dire wolf looks around then tilts its head to greet you in the lobby. An animated megalodon shark circles its prey in a conference room made of floor-to-ceiling screens before striking ...
Colossal Biosciences – the startup trying to revive extinct species such as the woolly mammoth with backing by media notables such as Tom Brady, George R.R. Martin, and Peter Jackson – announced a ...
Colossal Biosciences and the UAE are launching an ambitious BioVault project designed to preserve the DNA of life on Earth for future generations. Colossal Biosciences and UAE plan a BioVault to ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Colossal Biosciences has struck ...